Show simple item record

Safety and Pharmacokinetics Of Clofarabine In Combination With High-Dose Cytarabine and Liposomal Daunorubicin In Pediatric AML: Results Of a Phase 1 Combination Study By The ITCC Consortium

dc.contributor.authorZwaan, CM
dc.contributor.authorDworzak, M
dc.contributor.authorKlingebiel, T
dc.contributor.authorRossig, C
dc.contributor.authorLeverger, G
dc.contributor.authorStary, J
dc.contributor.authorDe Bont, ES
dc.contributor.authorRamnarain, S
dc.contributor.authorBertrand, Y
dc.contributor.authorGhazaly, EA
dc.contributor.authorReinhardt, D
dc.date.accessioned2015-02-23T12:53:38Z
dc.date.available2015-02-23T12:53:38Z
dc.date.issued2013-11-15
dc.identifier.issn0006-4971
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/6673
dc.relation.isreplacedby123456789/7699
dc.relation.isreplacedbyhttp://qmro.qmul.ac.uk/jspui/handle/123456789/7699
dc.titleSafety and Pharmacokinetics Of Clofarabine In Combination With High-Dose Cytarabine and Liposomal Daunorubicin In Pediatric AML: Results Of a Phase 1 Combination Study By The ITCC Consortium
dc.typeConference Proceeding
pubs.author-urlhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000331385005405&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a
pubs.author-urlhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000331385005405&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a
pubs.issue21
pubs.publication-statusPublished
pubs.volume122


Files in this item

Thumbnail
Name:
Blood_ITCC abstract_2013.doc
Size:
32.5Kb
Format:
application/
View/Open

This item appears in the following Collection(s)

Show simple item record